Progress in the Diagnosis and Control of Ebola Disease

  • Agnieszka Woźniak-Kosek
  • Jarosław Kosek
  • Jerzy Mierzejewski
  • Piotr Rapiejko
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 857)

Abstract

Ebola hemorrhagic fever is one of numerous viral hemorrhagic fevers. It is a severe, often fatal disease in humans and nonhuman primates (gorillas and chimpanzees). This article discusses the history of Ebola disease, already known routes of infection together with defining prevention methods and treatment trials. The importance of increasing awareness of the risk of disease among people who do not inhabit endemic regions is emphasized. This risk is associated especially with the increasing popularity of tourism to African countries, even to those where the virus is endemic. The research conducted over the years shows that three species of frugivorous bats are subjected to contamination by Ebola, but the infection is asymptomatic in them. It is believed that the saliva of these mammals and other body fluids may be a potential source of infection for primates and humans. In the laboratory, infection through small-particle aerosols has been demonstrated in primates, and airborne spread among humans is strongly suspected, although it has not yet been conclusively demonstrated. The importance of this route of transmission remains unclear. Poor hygienic conditions can aid the spread of the virus. These observations suggest approaches to the study of routes of transmission to and among humans.

Keywords

Ebola virus Epidemiology Diagnosis Prevention 

References

  1. Barrientos LG, O’Keefe BR, Bray M, Sanchez A, Gronenborm AM, Boyd MR (2003) Cyanovirin-N binds to the viral surface glycoprotein, GP 1,2 and inhibits infectivity of Ebola. Antiviral Res 58:47–56PubMedCrossRefGoogle Scholar
  2. Bente D, Gren J, Strong JE, Feldmann H (2009) Disease modeling for Ebola and Marburg viruses. Dis Model Mech 2:12–17PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bukreyev A, Rollin PE, Tate MK, Yang L, Zaki SR, Shieh W-J, Murphy BR, Collins PL, Sanchez A (2007) Successful topical respiratory tract immunization of primates against Ebola virus. J Virol 81:6379–6388PubMedCentralPubMedCrossRefGoogle Scholar
  4. Bwaka MA, Bonnet MJ, Calain P, Colebunders R, De Roo A, Guimard Y, Katwiki KR, Kibadi K, Kipasa MA, Kuvula KJ, Mapanda BB, Massamba M, Mupapa KD, Muyembe-Tamfum JJ, Ndaberey E, Peters CJ, Rollin PE, Van den Enden E (1999) Ebola hemorrhagic fever in Kikwit, Democratic Republic of Congo: clinical observation in 103 patients. J Infect Dis 179(Suppl):1–7CrossRefGoogle Scholar
  5. Centers for Disease Control and Prevention (2001) Outbreak of Ebola hemorrhagic fever Uganda, August 2000–January 2001. Morb Mortal Wkly Rep 9:73–77Google Scholar
  6. Feldmann H (2001) Are we any closer to combating Ebola infections? Lancet 375:1850–1852CrossRefGoogle Scholar
  7. Feldmann H, Geisbert TW (2011) Ebola hemorrhagic fever. Lancet 377:849–862PubMedCentralPubMedCrossRefGoogle Scholar
  8. GAR – Global Alert and Response (2014) http://www.who.int/csr/disease/ebola/maps/en/. Accessed on 30 Jan 2015
  9. Gear JH, Ryan J, Rossouw E (1978) A consideration of the diagnosis of dangerous infections fevers in South Africa. S Afr Med J 53:235–237PubMedGoogle Scholar
  10. Gonzalez JP, Pourrut X, Leroy E (2007) Ebola virus and other filoviruses. Curr Top Microbiol Immunol 315:363–387PubMedGoogle Scholar
  11. Jaax N, Jahrling P, Geisbert T, Geisbert J, Steele K, McKee K, Nagley D, Johnson E, Jaax G, Peters C (1995) Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 346:1669–1671PubMedCrossRefGoogle Scholar
  12. Jaax NK, Davis KJ, Geisbert TJ, Vogel P, Jaax GP, Topper M, Jahrling PB (1996) Lethal experimental infection of rhesus monkeys with Ebola-Zaire (Mayinga) virus by the oral and conjunctival route of exposure. Arch Pathol Lab Med 120:140–155PubMedGoogle Scholar
  13. Jahrling PB, Geisbert TW, Geisbert JB, Swearengen JR, Bray M, Jaax NK, Huggins JW, LeDuc JW, Peterset CJ (1999) Evaluation of immune globulin and recombinant interferon-alpha2b for treatment of experimental Ebola virus infections. J Infect Dis 179:224–234CrossRefGoogle Scholar
  14. Johnson E, Jaax N, White J, Jahrling P (1995) Lethal experimental infection of Rhesus monkeys by aerosolized Ebola virus. Int J Exp Pathol 76:227–236PubMedCentralPubMedGoogle Scholar
  15. Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A, Weingartl HM (2011) Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis 204:200–208PubMedCrossRefGoogle Scholar
  16. Ksiazek TG, Rollin PE, Jahrling PB, Johnson E, Dalgard DW, Peters CJ (1992) Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates. J Clin Microbiol 30:947–950PubMedCentralPubMedGoogle Scholar
  17. Ksiazek TG, Rollin PE, Williams AJ, Bressler DS, Martin ML, Swanepoel R, Burt FJ, Leman PA, Khan AS, Rowe AK, Mukunu R, Sachez A, Peters CJ (1999) Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo. J Infect Dis 179:177–187CrossRefGoogle Scholar
  18. Kudoyarova-Zubavichene NM, Sergeyev NN, Chepuronov AA, Netesov SV (1999) Preparation and use of hyperimmune serum for prophylaxis ant therapy of Ebola virus infections. J Infect Dis 179:218–223CrossRefGoogle Scholar
  19. Mupapa K, Massamba M, Kibadi K, Kuvula K, Bwaka A, Kipasa M, Colebunders R, Muyembe-Tamfum JJ, on behalf of the International Scientific and Technical Committee (1999) Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis 179:18–23CrossRefGoogle Scholar
  20. Olson PE, Hames CS, Benenson AS, Genovese EN (1996) The Thucydides syndrome: Ebola deja vu? (or Ebola reemergent?). Emerg Infect Dis 2:155–156PubMedCentralPubMedCrossRefGoogle Scholar
  21. Reed DS, Lackemeyer MG, Garza NL, Sullivan LJ, Nichols DK (2011) Aerosol exposure to Zaire Ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes Infect 13:930–936PubMedCrossRefGoogle Scholar
  22. Weingartl HM (2011) Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs. J Infect Dis 204:200–208PubMedCrossRefGoogle Scholar
  23. Weingartl HM, Embury-Hyatt C, Nfon C, Leung A, Smith G, Kobinger G (2012) Transmission of Ebola virus from pigs to non-human primates. Sci Rep 2:811. doi:10.1038/srep00811 PubMedCentralPubMedCrossRefGoogle Scholar
  24. WHO (1978) Ebola haemorrhagic fever in Zaire. Bull World Health Organ 56:271–293Google Scholar
  25. Zaki SR, Shieh WJ, Greer PW, Goldsmith CS, Ferebee T, Katshitshi J, Tshioko FK, Bwaka MA, Swanepoel R, Calain P, Khan AS, Lloyd AS, Rollin PE, Ksiazek TG, Peters CJ (1999) A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis 179:36–47CrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2015

Authors and Affiliations

  • Agnieszka Woźniak-Kosek
    • 1
  • Jarosław Kosek
    • 2
  • Jerzy Mierzejewski
    • 3
    • 4
  • Piotr Rapiejko
    • 2
  1. 1.Epidemiological Response Center of Polish Armed ForcesWarsawPoland
  2. 2.Otolaryngology ClinicMilitary Institute of MedicineWarsawPoland
  3. 3.Military Institute of Hygiene and EpidemiologyPuławyPoland
  4. 4.University of Technology and HumanitiesRadomPoland

Personalised recommendations